Topoisomerase II inhibition by aporphine alkaloids

Biochemical Pharmacology

Volumn 57, Issue 10, 1999, Pages 1141-1145

  Woo, Sung Ho ^a   Sun, Nan Jun ^b   Cassady, John M ^b   Snapka, Robert M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Aporphine alkaloid; Dicentrine; DNA binding; DNA intercalator; Intercalation; Topoisomerase II; Topoisomerase inhibitor

Indexed keywords

ALKALOID; APORPHINE DERIVATIVE; BULBOCAPNINE; DICENTRINE; DNA TOPOISOMERASE (ATP HYDROLYSING); GYRASE INHIBITOR; HYDROXYL GROUP; INTERCALATING AGENT; LIRIODENINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA DENATURATION; DRUG DNA BINDING; INTERCALATION COMPLEX; KIDNEY CELL; MOLECULAR MODEL; MONKEY; NONHUMAN; PRIORITY JOURNAL;

EID: 0033562662     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00018-0     Document Type: Article

References (20)

1. Woo S.H., Reynolds M.C., Sun N.J., Cassady J.M., Snapka R.M. Inhibition of topoisomerase II by liriodenine. Biochem Pharmacol. 54:1997;467-473.
2. Lu S.T., Wang S.J., Lai P.H., Lin C.M., Lin L.C. Studies on the alkaloids of Formosan Lauraceous plants. XV. Alkaloids of Lindera oldhamii Hemsl. Yakugaku Zasshi. 92:1972;910-917.
3. Shafiee A., Ghanbarpour A., Lalezari I., Lajevardi S. Alkaloids of Papaver genus. XI. Alkaloids of Glaucium vitellinum, population Isfahan. J Nat Prod. 42:1979;174-178.
4. Mayo S.L., Olafson B.D., Goddard W.A.I. DREIDING: A generic force field for molecular simulations. J Phys Chem. 94:1990;8897-8909.
5. Snapka R.M., Permana P.A., Marquit G., Shin C.-G. Two-dimensional agarose gel analysis of simian virus 40 DNA replication intermediates. Methods. 3:1991;73-82.
6. Snapka R.M. Analysis of SV40 DNA replication intermediates. Snapka R.M., The SV40 Replicon Model for Analysis of Anticancer Drugs. 1996;15-37 Academic Press, San Diego.
7. Permana P.A., Snapka R.M., Shen L.L., Chu D.T.W., Clement J.J., Plattner J.J. Quinobenoxazines: A class of novel antitumor quinolones and potent mammalian DNA topoisomerase II catalytic inhibitors. Biochemistry. 33:1994;11333-11339.
8. Snapka R.M., Yamasaki E.F. Topoisomerase II and termination of DNA replication. Snapka R.M., The SV40 Replicon Model for Analysis of Anticancer Drugs. 1996;65-100 Academic Press, San Diego.
9. Shin C.-G., Strayer J.M., Wani M.A., Snapka R.M. Rapid evaluation of topoisomerase inhibitors: Caffeine inhibition of topoisomerases in vivo. Teratog Carcinog Mutagen. 10:1990;41-52.
10. Pommier Y., Covey J.M., Kerrigan D., Markovits J., Pham R. DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalation. Nucleic Acids Res. 15:1987;6713-6731.
11. Snapka R.M., Powelson M.A., Strayer J.M. Swiveling and decatenation of replicating simian virus 40 genomes in vivo. Mol Cell Biol. 8:1988;515-521.
12. Snapka R.M., Woo S.H., Blokhin A.V., Witiak D.T. Inhibition of topoisomerase II by ICRF-193, the meso isomer of 2,3-bis(2,6-dioxopiperazin-4-yl)butane. Critical dependence on 2,3-butanediyl linker absolute configuration. Biochem Pharmacol. 52:1996;543-549.
13. Permana P.A., Ferrer C.A., Snapka R.M. Inverse relationship between catenation and superhelicity in newly replicated simian virus 40 daughter chromosomes. Biochem Biophys Res Commun. 201:1994;1510-1517.
14. Chen A.Y., Liu L.F. DNA topoisomerases: Essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol. 34:1994;191-218.
15. Störl K., Burckhardt G., Lown J.W., Zimmer C. Studies on the ability of minor groove binders to induce supercoiling in DNA. FEBS Lett. 334:1993;49-54.
16. Harrigan G.G., Gunatilaka A.A., Kingston D.G.I., Chan G.W., Johnson R.K. Isolation of bioactive and other oxoaporphine alkaloids from two annonaceous plants, Xylopia aethiopica and Miliusa cf. banacea. J Nat Prod. 57:1994;68-73.
17. Atwell G.J., Bos C.D., Baguley B.C., Denny W.A. Potential antitumor agents. 56. "Minimal" DNA-intercalating ligands as antitumor drugs: Phenylquinoline-8-carboxamides. J Med Chem. 31:1988;1048-1052.
18. Gabbay E.J., DePaolis A. Topography of nucleic acid helices in solutions. Steric requirements for intercalation. J Am Chem Soc. 93:1971;562-564.
19. Gabbay E.J., Scofield R.E., Baxter C.S. Steric effects on the intercalation of aromatic cations to deoxyribonucleic acid. J Am Chem Soc. 95:1973;7850-7858.
20. Yamamoto N., Okamoto T., Kawaguchi M. Novel intercalators of pyrylium dye into double-stranded DNA. Nucleic Acids Symp Ser. 29:1993;83-84.